The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration (FDA) and will be available within three months.
Known as VIZZ, from pharmaceutical company LENZ, the drops are an aceclidine ophthalmic solution that effectively treats presbyopia in adults. The once-daily drops offer relief from blurry near. vision for up to 10 hours.
The company:
WHAAAATTT??? This is too good to be true… I’m sending this to my eye doc first thing in the morning to see what he says.
Another magic liquid, like the German cartilage filler, that brings credit to science, and to the FDA for approving it.
Sounds similar to Vuity eyedrops.
Yes
A review of Vuity:
Vuity, taken daily, promises clear vision for up to 10 hours. But does it work?
I’ve found that Lutein and Zeaxanthin plus Astaxanthin has kept my presbyopia at bay. Also a good night sleep. I can read everything in the morning, but by the evening my presbyopia comes back. I take Lutein and Zeaxanthin in the morning. Maybe I need to take it twice daily?
FWIW my eye doc said:
The main issue is possible retinal detachment (oh, just that!). The previous version had a non-insignificant rate of retinal detachment and also has a lot of side effects (and tried it once and he himself experienced them).
Hmmm… yiu mean that I could dump my cheaters with these drops?
Sign me up.
I was so excited about this until I realized you have to keep using them a couple times a day.
Has anyone seen pricing yet?
And my guess is they might not work if you’ve had cataract surgery?
According to the Times article provided by Rapadmin, it’s $100 for a month’s supply. It also gives you pinkeye.
A revolutionary drug that will make presbyopia a thing of the past. Also, from what I’ve read, its active ingredient is aceclidine. It doesn’t have the side effects of other anticholinergics, such as focusing impairment. Surprisingly, it’s specific only to the muscle fibers that enable near vision. I wish the company continued success. I wonder if they could have developed the drug using artificial intelligence.